HI - Phase 1 Flashcards
SLE pathophysiology
Type III hypersensitivity resulting from the production of autoantibodies directed against soluble nuclear antigens (DNA, histones, other proteins) which form immune complexes that deposit and cause inflammatory effects throughout the body
- underlying cause is thought to be a combination of genetic predisposition and environmental triggers e.g. infection, UV light, medications
- genetic factors thought to be involved with delayed clearance of apoptotic bodies and increased likelihood of recognising these nuclear antigens as foreign
Common manifestations of SLE
Mnuemonic:
So Sorry, My Heart Rate Knows No Husband
Lupus autoantibodies
Antinuclear antibodies (ANA): high sensitivity but low specificity as found in other AI disease
More lupus specific:
- anti-Smith: small ribonucleoproteins
- anti-dsDNA
Anti-phospholipid – usually targets proteins bound to phospholipid, less specific as well
- anticardiolipin (syphilis false positive)
- lupus anticoagulant/antibody
- anti-B2 glycoprotein 1
Can lead to antiphospholipid syndrome which causes a hypercoagulable state leading to stroke, DVT and other clotting issues
Sources of reactive oxygen species
- Endogenous sources* – oxidative phosphorylation, redox reactions, antimicrobial defence
- Exogenous sources* – stress, air pollution, alcohol, smoking, radiation, infection
Antioxidant systems in the body
- Preventative* – stop the initial formation of free radicals e.g. chelators, melanin
- Radical scavenging* – mop up free radicals e.g. enzymes, vitamins, dietary sources, melatonin
- Repair* – DNA repair enzymes
Overview of anaemia
Anemia = decrease in blood oxygen carrying capacity due to low RBCs or haemoglobin
Hb definition: <120g/L in females, <140g/L in males
Can also categorise based on mechanism:
- decreased production
- blood loss
- increased destruction (haemolysis) – intravascular (DIC, TTP, mechanical valves) or extravascular (splenic destruction e.g. malaria, sickle cell)
Investigations used for anaemia
Full blood count – diagnose anaemia, determine MCV, reticulocytes indicate compensation
Peripheral blood smear – morphology of cells provides diagnostic information
Indicators of haemolysis – LDH release from RBCs, unconjugated bilirubin, haptoglobins which decrease in number when used to clear free Hb
Types of haemoglobin
Summary of thalassemias
Thalassemias result from defective synthesis of Hb globin chains, leading to imbalances in alpha or beta chains and ineffective erythropoiesis
Alpha thalassemia
Results from deletions of one or more of the four genes that contribute to alpha chains, number of genes deleted determines severity
- asymptomatic
- alpha thalassemia trait – mild microcytic anemia
- HbH disease – microcytic anemia
- hydrops fetalis – incompatible with life
Beta thalassemia
Results from mutations in the two genes that encode beta chains
- minor: only one allele bears a mutation leading to microcytic anemia
- intermedia: both alleles are mutated but some beta globin chain production is possible
- major: homozygous mutation in which no beta globin chains are produced, raised HbF and HbA2, completely dependent on transfusion
Autoimmune disorders of platelets, WBCs, RBCs
Immune thrombocytopenic purpura (ITP):
Low platelet count resulting in bleeding tendency and bruising/purpura
- generation of autoantibodies directed against platelet membrane antigens for unclear reasons results in excessive splenic destruction
- bone marrow is normal, and no other causes of low platelets are present
Autoimmune neutropenia:
Autoantibodies directed against neutrophil surface glycoproteins causing destruction which can occur in isolation or in association with another condition
- primary – not associated with other pathology, normally in children
- secondary – due to an underlying cause such as drugs, viruses
Autoimmune haemolytic anemia:
Significantly shortened RBC lifespan due to autoantibodies (IgG or IgM) directed against membrane antigens, classified depending on the antibody type which is determined by the direct Coomb’s test which is used for AIHA diagnosis
- warm AIHA – IgG predominant, antibodies most active at normal body temperature
- cold AIHA - IgM predominant, antibodies most active below normal body temperature
Malaria life cycle
Most clinically relevant causes of malaria – P. falciparum (Africa + Asia), P. vivax (Asia)
- Female Anopheles mosquito bites human and releases sporozoites into blood
- Sporozoites asymptomatically infect hepatocytes and multiply substantially
- Rupture of hepatocyte releases next stage of parasite into the blood where it now infects and multiplies in red blood cells, causing rupture
- Some gametocytes are released during this process which can be taken up by another mosquito where they reproduce and continue the cycle
Lymphocyte receptor diversity and clonal selection
Major mechanism of lymphocyte receptor diversity production is VDJ recombination:
- somatic recombination of variation, diversity, and junctional segments
- junctional diversity due to point mutations
Clonal selection = theory of adaptive immunity, VDJ recombination produces a massive array of different lymphocyte receptors with 10-100 of each, APCs will find the cognate lymphocyte and activate causing them to undergo proliferation to produce a substantial immune response
Central vs. peripheral tolerance
Central tolerance
- T cells (thymus): double positive lymphoid progenitors are tested for binding to MHC molecules and either destroyed if binding is too strong/weak or sent down a committed pathway and tested again by medullary cells through AIRE expression
- B cells (marrow): receptors are produced via VDJ recombination and tested against self-antigens, receptor editing can occur if autoreactivity is present
Peripheral tolerance
both B and T cells in the periphery are checked for autoreactivity and can be suppressed through various mechanisms (anergy, suppression by regulatory cells, apoptosis)
Mechanisms of autoimmunity
- Reversal of anergy due to upregulation of costimulatory molecules in inflammation
- Emergency reversal of tolerance to aid in fighting infection
- Local tissue damage releasing intracellular or immune privileged antigens
- Alteration of self-antigens
- Hypersensitivity reactions
- Molecular mimicry
Common immunopharmacological drugs
Process of red blood cell maturation + regulation
Erythropoiesis = process of red blood cell production
- Begins with common myeloid progenitor which differentiates into an erythroblast
- Progressive maturation with loss of most organelles and nucleus to form reticulocytes
- Reticulocytes circulate in blood for 1-2 days before losing remaining organelles and becoming mature erythrocytes
After circulating for 120 days, senescent red blood cells are selected out and destroyed by macrophages of the reticuloendothelial system, primarily in the liver and spleen
Major regulation of this process is through the production of the endocrine hormone erythropoietin (EPO) which is secreted by the kidney in response to low oxygen in blood